Ozlem Aydin Isak

Sunitinib or Pazopanib: Is There Any Difference Between Tyrosine Kinase Inhibitors in the Pre-Nivolumab Setting in Metastatic Renal Cell Carcinoma?

M. Dogan, M. Yılmaz, O. Bal, 2020, Cureus.